Skip to content
YCW21· Other

Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

InactiveChecked 19h ago
Batch
W21
Status, per YC
Inactive
Team size
5
HQ
Los Angeles, CA
In W21336 companies, 30% AI
forcytebio.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Forcyte Biotechnologies

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Los Angeles, CA, USA

Forcyte Biotechnologies: questions

Which YC batch was Forcyte Biotechnologies in?

Forcyte Biotechnologies was in Y Combinator's Winter 2021 batch (W21).

Is Forcyte Biotechnologies still active?

Y Combinator lists Forcyte Biotechnologies as inactive.

Where is Forcyte Biotechnologies based?

Forcyte Biotechnologies lists Los Angeles, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.